These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1311 related items for PubMed ID: 26246395

  • 1. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF.
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [Abstract] [Full Text] [Related]

  • 2. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK, Kao AH, Schott LL, Elliott JR, Toledo FG, Kuller L, Manzi S, Wasko MC.
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [Abstract] [Full Text] [Related]

  • 3. Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
    Nirk EL, Reggiori F, Mauthe M.
    EMBO Mol Med; 2020 Aug 07; 12(8):e12476. PubMed ID: 32715647
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.
    Furst DE.
    Lupus; 1996 Jun 07; 5 Suppl 1():S11-5. PubMed ID: 8803904
    [Abstract] [Full Text] [Related]

  • 5. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM, Almeida CAF, Pereira B, Costa KCM, Pinheiro FA, Maia LDB, Trindade CM, Garcia RCT, Torres LH, Diwan S, Boralli VB.
    Pain Physician; 2020 Aug 07; 23(4S):S351-S366. PubMed ID: 32942793
    [Abstract] [Full Text] [Related]

  • 6. How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice.
    Fairley JL, Nikpour M, Mack HG, Brosnan M, Saracino AM, Pellegrini M, Wicks IP.
    Intern Med J; 2023 Mar 07; 53(3):311-317. PubMed ID: 35969110
    [Abstract] [Full Text] [Related]

  • 7. Predictors of Initial Hydroxychloroquine Receipt Among Medicaid Beneficiaries With Incident Systemic Lupus Erythematosus.
    Pryor KP, Xu C, Collins JE, Costenbader KH, Feldman CH.
    Arthritis Care Res (Hoboken); 2022 Aug 07; 74(8):1263-1268. PubMed ID: 33555101
    [Abstract] [Full Text] [Related]

  • 8. Long-term effectiveness of antimalarial drugs in rheumatic diseases.
    Aviña-Zubieta JA, Galindo-Rodriguez G, Newman S, Suarez-Almazor ME, Russell AS.
    Ann Rheum Dis; 1998 Oct 07; 57(10):582-7. PubMed ID: 9893568
    [Abstract] [Full Text] [Related]

  • 9. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
    Morita S, Takahashi T, Yoshida Y, Yokota N.
    Ther Drug Monit; 2016 Apr 07; 38(2):259-67. PubMed ID: 26587870
    [Abstract] [Full Text] [Related]

  • 10. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A, Peana M, Noor S, Lysiuk R, Menzel A, Gasmi Benahmed A, Bjørklund G.
    Appl Microbiol Biotechnol; 2021 Feb 07; 105(4):1333-1343. PubMed ID: 33515285
    [Abstract] [Full Text] [Related]

  • 11. [Current view on chloroquine derivative treatment from rheumatologist perspective and possible ocular side effects].
    Pawlak-Buś K, Gaca-Wysocka M, Grzybowski A, Leszczyński P.
    Pol Merkur Lekarski; 2016 Mar 07; 40(237):202-6. PubMed ID: 27088206
    [Abstract] [Full Text] [Related]

  • 12. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C, Moroni G.
    Expert Opin Drug Saf; 2017 Mar 07; 16(3):411-419. PubMed ID: 27927040
    [Abstract] [Full Text] [Related]

  • 13. Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study.
    Barton JC, Barton JC, Bertoli LF.
    Arch Immunol Ther Exp (Warsz); 2022 Apr 11; 70(1):14. PubMed ID: 35403913
    [Abstract] [Full Text] [Related]

  • 14. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
    Wakiya R, Ueeda K, Shimada H, Nakashima S, Kameda T, Miyatake N, Kato M, Miyagi T, Sugihara K, Mizusaki M, Mino R, Kadowaki N, Dobashi H.
    Clin Rheumatol; 2022 Nov 11; 41(11):3345-3353. PubMed ID: 35849246
    [Abstract] [Full Text] [Related]

  • 15. Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?
    Dima A, Jurcut C, Arnaud L.
    Joint Bone Spine; 2021 May 11; 88(3):105143. PubMed ID: 33515791
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
    Wakiya R, Kameda T, Nakashima S, Shimada H, Fahmy Mansour MM, Kato M, Miyagi T, Kadowaki N, Dobashi H.
    Intern Med; 2020 Sep 01; 59(17):2105-2112. PubMed ID: 32522920
    [Abstract] [Full Text] [Related]

  • 17. The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.
    Martinez GP, Zabaleta ME, Di Giulio C, Charris JE, Mijares MR.
    Curr Pharm Des; 2020 Sep 01; 26(35):4467-4485. PubMed ID: 32634079
    [Abstract] [Full Text] [Related]

  • 18. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
    Munster T, Gibbs JP, Shen D, Baethge BA, Botstein GR, Caldwell J, Dietz F, Ettlinger R, Golden HE, Lindsley H, McLaughlin GE, Moreland LW, Roberts WN, Rooney TW, Rothschild B, Sack M, Sebba AI, Weisman M, Welch KE, Yocum D, Furst DE.
    Arthritis Rheum; 2002 Jun 01; 46(6):1460-9. PubMed ID: 12115175
    [Abstract] [Full Text] [Related]

  • 19. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
    Cohen S, Clowse M, Pardo P, Bhattacharya I, Menon S, Gourley I, Diehl A.
    Clin Ther; 2016 Jun 01; 38(6):1417-1434.e2. PubMed ID: 27112532
    [Abstract] [Full Text] [Related]

  • 20. Hydroxychloroquine: a multifaceted treatment in lupus.
    Costedoat-Chalumeau N, Dunogué B, Morel N, Le Guern V, Guettrot-Imbert G.
    Presse Med; 2014 Jun 01; 43(6 Pt 2):e167-80. PubMed ID: 24855048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.